Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILYSYS INCAGYS · Entity 897 | Director | May 27, 2026 | May 29, 2026 |
| HARTE HANKS INCHRTH · Entity 7438 | Director | March 21, 2020 | September 02, 2020 |
| MAGNACHIP SEMICONDUCTOR CorpMX · Entity 6704 | Director | June 01, 2023 | June 05, 2023 |
| Red Lion Hotels CORPRLH · Entity 141073 | Director | January 09, 2017 | January 10, 2017 |
| Rocky Mountain Chocolate Factory, Inc.RMCF · Entity 1473 | Director | September 22, 2026 | September 22, 2026 |
| SPS COMMERCE INCSPSC · Entity 4230 | Director | May 31, 2018 | June 04, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILYSYS INC
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,424 |
Reported balance
After 2026-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 1,424 · Balance 1,424 F1: Restricted stock units granted under the Agilysys, Inc. 2024 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of Agilysys, Inc. F2: The restricted stock units vest on May 27, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted under the Agilysys, Inc. 2024 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of Agilysys, Inc.
F2: The restricted stock units vest on May 27, 2027.
HARTE HANKS INC
Report date March 21, 2020 · Filed September 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,676 |
Ending reported balance
After 2020-07-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-03-21 · Exercise / conversion · Acquired 23,136 · Balance 31,992 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. Row 2 · 2020-07-22 · Exercise / conversion · Acquired 6,684 · Balance 38,676 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-03-21 · Exercise / conversion · Disposed 23,136 · Balance 0 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. F2: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-07-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-07-22 · Exercise / conversion · Disposed 6,684 · Balance 0 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. F3: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. On August 3, 2017, the reporting person was granted 6,382 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date. We accelerated the vesting of these two awards in connection with the reporting person's departure from the Board. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.
F2: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date.
F3: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. On August 3, 2017, the reporting person was granted 6,382 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date. We accelerated the vesting of these two awards in connection with the reporting person's departure from the Board.
MAGNACHIP SEMICONDUCTOR Corp
Report date June 01, 2023 · Filed June 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,445 |
Reported balance
After 2023-06-01 transaction · row 1
1 source rowRow 1 · 2023-06-01 · Grant · Acquired 20,657 · Balance 124,445 |
Red Lion Hotels CORP
Report date January 09, 2017 · Filed January 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,516 |
Reported balance
After 2017-01-09 transaction · row 1
1 source rowRow 1 · 2017-01-09 · Grant · Acquired 2,071 · Balance 64,516 F1: Represents the portion of first quarter 2017 director fees paid to the recipient in stock. Based on the closing price of our common stock on January 3, 2017 of $8.45. F2: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the portion of first quarter 2017 director fees paid to the recipient in stock. Based on the closing price of our common stock on January 3, 2017 of $8.45.
F2: Not applicable.
Rocky Mountain Chocolate Factory, Inc.
Report date September 22, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,079 |
Reported balance
After 2026-09-22 transaction · row 1
1 source rowRow 1 · 2026-09-22 · Grant · Acquired 7,000 · Balance 110,079 |
SPS COMMERCE INC
Report date May 31, 2018 · Filed June 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 913 |
Reported balance
After 2018-05-31 transaction · row 1
1 source rowRow 1 · 2018-05-31 · Grant · Acquired 913 · Balance 913 F1: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2018, provided the recipient remains a member of the board as of the vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.43 · Expires 2025-05-31 | Direct | 3,285 |
Reported balance
After 2018-05-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-05-31 · Grant · Acquired 3,285 · Balance 3,285 F2: Shares subject to this option vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2018, provided the recipient remains a member of the board as of the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2018, provided the recipient remains a member of the board as of the vesting date.
F2: Shares subject to this option vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2018, provided the recipient remains a member of the board as of the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Vitamin Shoppe, Inc.
Report date December 16, 2019 · Filed December 16, 2019
Section 16 reporting ended · disclosed 2019-12-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01SEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-12-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-12-16 · Disposition to issuer · Disposed 12,419 · Balance 19,893 F1: Disposed of pursuant to the Agreement and Plan of Merger dated as of August 7, 2019, by and among Vitamin Shoppe, Inc., Franchise Group, Inc. (formerly known as Liberty Tax, Inc.) ("Parent") and Valor Acquisition, LLC ("Merger Sub"), a wholly owned subsidiary of Parent, as amended by the First Amendment to Agreement and Plan of Merger dated November 11, 2019 (as amended, the "Merger Agreement"), pursuant to which Vitamin Shoppe, Inc. merged with and into Merger Sub (the "Merger") effective December 16, 2019. Row 2 · 2019-12-16 · Disposition to issuer · Disposed 19,893 · Balance 0 F2: Pursuant to the Merger Agreement, each restricted stock unit outstanding immediately prior to the effective time of the Merger was canceled and converted into the right to receive an amount in cash, without interest, equal to (i) $6.50 multiplied by (ii) the total number of shares of common stock subject thereto. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger dated as of August 7, 2019, by and among Vitamin Shoppe, Inc., Franchise Group, Inc. (formerly known as Liberty Tax, Inc.) ("Parent") and Valor Acquisition, LLC ("Merger Sub"), a wholly owned subsidiary of Parent, as amended by the First Amendment to Agreement and Plan of Merger dated November 11, 2019 (as amended, the "Merger Agreement"), pursuant to which Vitamin Shoppe, Inc. merged with and into Merger Sub (the "Merger") effective December 16, 2019.
F2: Pursuant to the Merger Agreement, each restricted stock unit outstanding immediately prior to the effective time of the Merger was canceled and converted into the right to receive an amount in cash, without interest, equal to (i) $6.50 multiplied by (ii) the total number of shares of common stock subject thereto.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2022 Filed Jun 14, 2022 22:01 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 100 | $38.20 | $3,820.00 |
DisclosureSEC source: 0001209191-22-036776 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,528 Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:05 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 2,322 | $43.06 | $99,985.32 |
DisclosureSEC source: 0001209191-22-035813 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,428 F1 · security: Restricted shares granted under the Agilysys, Inc. 2020 Equity Incentive Plan. The shares vest on March 31, 2023. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 00:50 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 300 | $34.82 | $10,446.00 |
DisclosureSEC source: 0001209191-22-005752 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,106 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.52 to $35.05, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:10 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | GrantCommon Stock | 10,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-034889 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,094 Read SEC document |
| August 18, 2021 Filed Aug 18, 2021 21:26 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 295 | $50.46 | $14,885.70 |
DisclosureSEC source: 0001209191-21-052279 · doc4.xml · nonDerivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,806 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.18 to $50.76, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 21:26 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 800 | $51.45 | $41,160.00 |
DisclosureSEC source: 0001209191-21-052279 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,511 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.98 to $51.90, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:56 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 1,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036883 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,711 F1 · security: Restricted shares granted under the Agilysys, Inc. 2020 Equity Incentive Plan. The shares vest on March 31, 2022. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 19:16 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 4,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059935 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,276 F1 · security: Restricted shares granted under the Agilysys, Inc. 2020 Equity Incentive Plan. The shares vest on March 31, 2021. Read SEC document |
| July 22, 2020 Filed Sep 2, 2020 00:27 UTC | HARTE HANKS INC HRTH · Entity 7438 | Exercise / conversionRestricted Stock Units · Derivative | 6,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019164 · rdgdoc.xml · derivative · entry 4 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,684 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. On August 3, 2017, the reporting person was granted 6,382 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date. We accelerated the vesting of these two awards in connection with the reporting person's departure from the Board. F3 · derivative.expiration_date: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. On August 3, 2017, the reporting person was granted 6,382 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date. We accelerated the vesting of these two awards in connection with the reporting person's departure from the Board. Read SEC document |
| July 22, 2020 Filed Sep 2, 2020 00:27 UTC | HARTE HANKS INC HRTH · Entity 7438 | Exercise / conversionCommon Stock | 6,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-019164 · rdgdoc.xml · nonDerivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 20:16 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | GrantCommon Stock | 18,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019653 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,409 Read SEC document |
| March 21, 2020 Filed Sep 2, 2020 00:27 UTC | HARTE HANKS INC HRTH · Entity 7438 | Exercise / conversionRestricted Stock Units · Derivative | 23,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019164 · rdgdoc.xml · derivative · entry 3 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date. F2 · derivative.expiration_date: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date. Read SEC document |
| March 21, 2020 Filed Sep 2, 2020 00:27 UTC | HARTE HANKS INC HRTH · Entity 7438 | Exercise / conversionCommon Stock | 23,136 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-019164 · rdgdoc.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. Read SEC document |
| March 17, 2020 Filed Mar 23, 2020 13:46 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 300 | $16.74 | $5,022.00 |
DisclosureSEC source: 0001209191-20-020580 · doc4.xml · nonDerivative · entry 4 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,888 Read SEC document |
| March 16, 2020 Filed Mar 23, 2020 13:46 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 200 | $17.30 | $3,460.00 |
DisclosureSEC source: 0001209191-20-020580 · doc4.xml · nonDerivative · entry 3 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,588 Read SEC document |
| March 16, 2020 Filed Mar 23, 2020 13:46 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 300 | $17.15 | $5,145.00 |
DisclosureSEC source: 0001209191-20-020580 · doc4.xml · nonDerivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,388 Read SEC document |
| March 16, 2020 Filed Mar 23, 2020 13:46 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 300 | $17.02 | $5,106.00 |
DisclosureSEC source: 0001209191-20-020580 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,088 Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:49 UTC | Vitamin Shoppe, Inc. VSI · Entity 16967 | Disposition to issuerCommon Stock, par value $0.01 | 19,893 | $6.50 | $129,304.50 |
DisclosureSEC source: 0000899243-19-029273 · doc4.xml · nonDerivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Pursuant to the Merger Agreement, each restricted stock unit outstanding immediately prior to the effective time of the Merger was canceled and converted into the right to receive an amount in cash, without interest, equal to (i) $6.50 multiplied by (ii) the total number of shares of common stock subject thereto. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:49 UTC | Vitamin Shoppe, Inc. VSI · Entity 16967 | Disposition to issuerCommon Stock, par value $0.01 | 12,419 | $6.50 | $80,723.50 |
DisclosureSEC source: 0000899243-19-029273 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,893 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger dated as of August 7, 2019, by and among Vitamin Shoppe, Inc., Franchise Group, Inc. (formerly known as Liberty Tax, Inc.) ("Parent") and Valor Acquisition, LLC ("Merger Sub"), a wholly owned subsidiary of Parent, as amended by the First Amendment to Agreement and Plan of Merger dated November 11, 2019 (as amended, the "Merger Agreement"), pursuant to which Vitamin Shoppe, Inc. merged with and into Merger Sub (the "Merger") effective December 16, 2019. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 20:56 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 1,200 | $24.48 | $29,376.00 |
DisclosureSEC source: 0001209191-19-060834 · doc4.xml · nonDerivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,788 Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 20:56 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 700 | $24.24 | $16,968.00 |
DisclosureSEC source: 0001209191-19-060834 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,588 Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:31 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | GrantCommon Stock | 19,403 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-021974 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,908 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:10 UTC | Vitamin Shoppe, Inc. VSI · Entity 16967 | GrantCommon Stock, par value $0.01 | 19,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001360530-19-000048 · wf-form4_156209820036222.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,312 F1 · shares: These shares are restricted stock units that were issued pursuant to the Registrant's 2018 Long-Term Incentive Plan, as the annual award to directors pursuant to the Director Compensation Plan and Stock Ownership Guidelines. Each restricted stock unit represents a contingent right to receive one share of common stock. Restricted stock units vest in four equal quarterly installments on October 1, 2019, January 2, 2020 April 1, 2020 and July 1, 2020. Read SEC document |
| May 28, 2019 Filed May 30, 2019 21:53 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 3,308 | $22.67 | $74,992.36 |
DisclosureSEC source: 0001209191-19-033508 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 F1 · security: Restricted shares granted under the Agilysys, Inc. 2016 Stock Incentive Plan. The shares vest on March 31, 2020. Read SEC document |
| March 21, 2019 Filed Mar 28, 2019 13:26 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 23,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-003518 · wf-form4_155377958592444.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,676 F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan and the corresponding Restricted Stock Unit Award Agreement and vest following a period of one full year from the date of grant. F2 · balance_after: These securities consist of (i) the 23,136 RSUs reported on this form and (ii) 38,676. Read SEC document |
| January 03, 2019 Filed Jan 3, 2019 18:50 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 1,355 | $2.42 | $3,279.10 |
DisclosureSEC source: 0001628280-19-000069 · wf-form4_154654138516737.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,450 F1 · shares: These shares were granted pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan in accordance with a pre-established election made by the reporting person to receive shares of common stock in lieu of a portion of the reporting person's director fees. The number of shares granted is based on the closing stock price on the last trading day of the preceding fiscal quarter. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 15:38 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 460 | $7.13 | $3,279.80 |
DisclosureSEC source: 0001628280-18-012205 · wf-form4_153849471208639.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,095 F1 · shares: These shares were granted pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan in accordance with a pre-established election made by the reporting person to receive shares of common stock in lieu of a portion of the reporting person's director fees. The number of shares granted is based on the closing stock price on the last trading day of the preceding fiscal quarter. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 13:01 UTC | HARTE HANKS INC HHS · Entity 7438 | Exercise / conversionRestricted Stock Units · Derivative | 2,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-010389 · wf-form4_153330126685263.xml · derivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,255 Underlying: Common Stock · 2,127 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into Common Stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2017, the reporting person was granted 6,382 Restricted Stock Units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On August 3, 2017, the reporting person was granted 6,382 Restricted Stock Units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 13:01 UTC | HARTE HANKS INC HHS · Entity 7438 | Exercise / conversionCommon Stock | 2,127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-010389 · wf-form4_153330126685263.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into Common Stock on a one-for-one basis. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 18:12 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 6,835 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-009745 · wf-form4_153297430904638.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,725 F1 · price: These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan, and vest in three equal annual installments. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 20:05 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | GrantCommon Stock | 17,489 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-020570 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,505 Read SEC document |
| July 16, 2018 Filed Jul 16, 2018 18:42 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 236 | $11.10 | $2,619.60 |
DisclosureSEC source: 0001628280-18-009236 · wf-form4_153176655689794.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508 F1 · shares: These shares were granted pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan in accordance with a pre-established election made by the reporting person to receive shares of common stock in lieu of a portion of the reporting person's director fees. The number of shares granted is based on the closing stock price on the last trading day of the preceding fiscal quarter. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:11 UTC | Vitamin Shoppe, Inc. VSI · Entity 16967 | GrantCommon Stock | 10,948 | $6.85 | $74,993.80 |
DisclosureSEC source: 0001360530-18-000073 · wf-form4_153082148380617.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,419 F1 · shares: These shares are restricted stock units that were issued pursuant to the Registrant's 2018 Long-Term Incentive Plan as the annual award to directors pursuant to the Director Compensation Plan and Stock Ownership Guidelines. Each restricted stock unit represents a contingent right to receive one share of common stock. Restricted stock units vest in four equal quarterly installments on October 1, 2018, January 2, 2019, April 1, 2019 and July 1, 2019. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:51 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 5,274 | $14.22 | $74,996.28 |
DisclosureSEC source: 0001209191-18-035401 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,580 F1 · security: Restricted shares granted under the Agilysys, Inc. 2016 Stock Incentive Plan. The shares vest on March 31, 2019. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:39 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 3,285 | $0.00 Strike: $74.43 | $0.00 |
DisclosureSEC source: 0001209191-18-035260 · doc4.xml · derivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,285 Underlying: Common Stock · 3,285 shares Expires 2025-05-31 F2 · derivative.exercise_date: Shares subject to this option vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2018, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:39 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 913 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035260 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 913 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2018, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 03, 2018 Filed May 7, 2018 21:05 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 4,911 | $0.00 Strike: $71.57 | $0.00 |
DisclosureSEC source: 0001209191-18-028368 · doc4.xml · derivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,911 Underlying: Common Stock · 4,911 shares Expires 2025-05-03 F1 · derivative.exercise_date: Shares subject to this option vest in equal monthly installments over three years commencing on the first day of the calendar month following the initial appointment or election to the board (March 16, 2018), provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:12 UTC | Vitamin Shoppe, Inc. VSI · Entity 16967 | GrantCommon Stock | 1,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001360530-18-000046 · wf-form4_152477352437054.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471 F1 · shares: Each restricted stock unit granted represents a right contingent on time vesting to receive one share of Common Stock. Read SEC document |
| April 13, 2018 Filed Apr 13, 2018 16:03 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 272 | $9.16 | $2,491.52 |
DisclosureSEC source: 0001628280-18-004240 · wf-form4_152363542134308.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272 F1 · shares: These shares were granted pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan in accordance with a pre-established election made by the reporting person to receive shares of common stock in lieu of a portion of the reporting person's director fees. The number of shares granted is based on the closing stock price on the last trading day of the preceding fiscal quarter. F2 · balance_after: All share amounts reflect adjustment for the issuer's 1-for-10 reverse stock split effective January 31, 2018. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:42 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | PurchaseCommon Stock | 3,600 | $9.01 | $32,432.04 |
DisclosureSEC source: 0000899243-18-003888 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,016 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $8.945 to $9.095 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 17:39 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantRestricted Stock Units · Derivative | 63,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-008084 · wf-form4_150186836710750.xml · derivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,829 Underlying: Common Stock · 63,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan and vest in three equal installments on the first through third anniversaries of the grant date. F2 · derivative.expiration_date: These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan and vest in three equal installments on the first through third anniversaries of the grant date. Read SEC document |
| July 12, 2017 Filed Jul 14, 2017 20:30 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | GrantStock Option (Right to Buy) · Derivative | 11,833 | $0.00 Strike: $10.35 | $0.00 |
DisclosureSEC source: 0000899243-17-018273 · doc4.xml · derivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,833 Underlying: Common Stock · 11,833 shares Expires 2027-07-12 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full, subject to continued service, on the earlier of 7/12/2018 and the meeting date of the Issuer's next annual meeting of stockholders. Read SEC document |
| July 12, 2017 Filed Jul 14, 2017 20:30 UTC | MAGNACHIP SEMICONDUCTOR Corp MX · Entity 6704 | GrantCommon Stock | 5,797 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018273 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,416 Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 22:36 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 7,113 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-17-000497 · edgar.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,306 F1 · security: Restricted shares granted under the Agilysys, Inc. 2016 Stock Incentive Plan. The shares vest on March 31, 2018. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 21:02 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 3,144 | $9.23 | $29,019.12 |
DisclosureSEC source: 0000950138-17-000220 · edgar.xml · nonDerivative · entry 2 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,193 F1 · price: Weighted average price. Shares purchased at prices between $9.11 and $9.34. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC | AGILYSYS INC AGYS · Entity 897 | PurchaseCommon Stock | 700 | $9.30 | $6,510.00 |
DisclosureSEC source: 0000950138-17-000220 · edgar.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,049 Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 18:17 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 2,071 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-003252 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,516 F1 · shares: Represents the portion of first quarter 2017 director fees paid to the recipient in stock. Based on the closing price of our common stock on January 3, 2017 of $8.45. F2 · price: Not applicable. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 16:41 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 2,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-145589 · doc4.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,445 F1 · shares: Represents the portion of fourth quarter 2016 director fees paid to the recipient in stock. Based on the closing price of our common stock on October 3, 2016 of $8.22. F2 · price: Not applicable. Read SEC document |
| September 15, 2016 Filed Sep 20, 2016 01:44 UTC | AGILYSYS INC AGYS · Entity 897 | GrantCommon Stock | 6,071 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-16-001353 · edgar.xml · nonDerivative · entry 1 KEATING MELVIN L · CIK 0001263463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,349 F1 · security: Restricted shares granted under the Agilysys, Inc. 2016 Stock Incentive Plan. The shares vest on March 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.